Nothing Special   »   [go: up one dir, main page]

ES2123008T3 - Secuencias de adn que codifican polipeptido de gelonina. - Google Patents

Secuencias de adn que codifican polipeptido de gelonina.

Info

Publication number
ES2123008T3
ES2123008T3 ES92919264T ES92919264T ES2123008T3 ES 2123008 T3 ES2123008 T3 ES 2123008T3 ES 92919264 T ES92919264 T ES 92919264T ES 92919264 T ES92919264 T ES 92919264T ES 2123008 T3 ES2123008 T3 ES 2123008T3
Authority
ES
Spain
Prior art keywords
gelonin
dna sequences
sequences coding
gene
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92919264T
Other languages
English (en)
Inventor
Michael G Rosenblum
Kenneth L Beattie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Development Foundation
Original Assignee
Research Development Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Development Foundation filed Critical Research Development Foundation
Application granted granted Critical
Publication of ES2123008T3 publication Critical patent/ES2123008T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6819—Plant toxins
    • A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

LA INVENCION SUMINISTRA UNA SECUENCIA NUCLEOTIDA PARA UN GEN SINTETICO PARA LA GELONINA DE LA TOXINA DE LAS PLANTAS Y UN PROCESO PARA LA PRODUCIR, CLONAR Y EXPRESAR ESTE GEN SINTETICO. LA SECUENCIA DE DNA PARA UN GEN SINTETICO DE GELONINA SE MUESTRA EN LA IDENTIFICACION DE SECUENCIA NUMERO 1. LA INVENCION TAMBIEN SUMINISTRA VECTORES DE EXPRESION QUE CONTIENE LA SECUENCIA DE DNA PARA LA GELONINA Y CELULAS TRANSFORMADAS CON ESTOS VECTORES. ADEMAS, SE PRESENTA UNA INMUNOTOXINA QUE COMPRENDE UN ANTICUERPO CONJUGADO CON LA GELONINA DE LA PROTEINA.
ES92919264T 1991-09-06 1992-08-21 Secuencias de adn que codifican polipeptido de gelonina. Expired - Lifetime ES2123008T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75594991A 1991-09-06 1991-09-06

Publications (1)

Publication Number Publication Date
ES2123008T3 true ES2123008T3 (es) 1999-01-01

Family

ID=25041367

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92919264T Expired - Lifetime ES2123008T3 (es) 1991-09-06 1992-08-21 Secuencias de adn que codifican polipeptido de gelonina.

Country Status (18)

Country Link
US (1) US5624827A (es)
EP (1) EP0602144B1 (es)
JP (1) JPH06510431A (es)
KR (1) KR100270195B1 (es)
CN (1) CN1047402C (es)
AT (1) ATE173023T1 (es)
AU (1) AU679427B2 (es)
CA (1) CA2115049C (es)
DE (1) DE69227519T2 (es)
DK (1) DK0602144T3 (es)
ES (1) ES2123008T3 (es)
FI (1) FI113547B (es)
IL (1) IL103057A (es)
NO (1) NO317659B1 (es)
NZ (1) NZ244220A (es)
RU (1) RU2142015C1 (es)
WO (1) WO1993005168A1 (es)
ZA (1) ZA926705B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317009A (en) * 1991-08-26 1994-05-31 New York University Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof
US6146850A (en) * 1991-11-04 2000-11-14 Xoma Corporation Proteins encoding gelonin sequences
US5621083A (en) * 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
US5837491A (en) * 1991-11-04 1998-11-17 Xoma Corporation Polynucleotides encoding gelonin sequences
US5869619A (en) * 1991-12-13 1999-02-09 Xoma Corporation Modified antibody variable domains
CA2507749C (en) * 1991-12-13 2010-08-24 Xoma Corporation Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
DE69432412T2 (de) * 1993-05-12 2004-01-29 Xoma Corp Gelonin und einen antikörper entahltende immuntoxine
US20030166169A1 (en) * 1998-01-16 2003-09-04 Padgett Hal S. Method for constructing viral nucleic acids in a cell-free manner
ZA200305980B (en) * 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
EP1414471B1 (en) 2001-07-17 2012-06-13 Research Development Foundation Therapeutic agents comprising pro-apoptotic proteins
US20040013691A1 (en) * 2002-06-12 2004-01-22 Rosenblum Michael G. Immunotoxin as a therapeutic agent and uses thereof
BR0315270A (pt) 2002-10-16 2005-08-30 Euro Celtique Sa Anticorpo isolado ou um fraguemento de anticorpo que se liga a antìgeno, anticorpo monoclonal, hibridona, molécula de ácido nucleico isolada, composição farmacêutica, artigo de fabricação, polipeptìdeo de fusão e métodos para melhorar um sintoma de um distúrbio relacionado com o ca125/0772p e para ajudar na identificação de um anticorpo ou fragmento de anticorpo que se liga a antìgeno
AU2006210769A1 (en) * 2005-02-01 2006-08-10 Research Development Foundation BLyS fusion proteins for targeting BLyS receptor and methods for treatment of B-cell proliferative disorders
US8759036B2 (en) * 2011-03-21 2014-06-24 Affymetrix, Inc. Methods for synthesizing pools of probes
US20130109596A1 (en) 2011-09-26 2013-05-02 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
WO2014153188A2 (en) 2013-03-14 2014-09-25 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
US9096840B2 (en) 2012-10-04 2015-08-04 Research Development Foundation Serine protease molecules and therapies
CN115927293A (zh) 2014-12-09 2023-04-07 生命技术公司 高效小体积核酸合成
EP3359669B1 (en) 2015-10-06 2020-05-13 Pierce Biotechnology, Inc. Devices and methods for producing proteins
EP3814494B1 (en) 2018-06-29 2023-11-01 Thermo Fisher Scientific GENEART GmbH High throughput assembly of nucleic acid molecules
GB201905303D0 (en) 2019-04-15 2019-05-29 Thermo Fisher Scient Geneart Gmbh Multiplex assembly of nucleic acid molecules
WO2021178809A1 (en) 2020-03-06 2021-09-10 Life Technologies Corporation High sequence fidelity nucleic acid synthesis and assembly
WO2024132094A1 (en) 2022-12-19 2024-06-27 Thermo Fisher Scientific Geneart Gmbh Retrieval of sequence-verified nucleic acid molecules
GB2628173A (en) 2023-03-17 2024-09-18 Thermo Fisher Scient Geneart Gmbh Methods of producing modified nucleic acid sequences for eliminating adverse splicing events

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888415A (en) * 1985-03-04 1989-12-19 Dana-Farber Cancer Institute, Inc. Gelonin immunotoxin
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
US5290914A (en) * 1988-04-28 1994-03-01 Mycogen Corporation Hybrid diphtheria-B.t. pesticidal toxins
IE912716A1 (en) * 1990-08-14 1992-02-26 Res Dev Foundation Protein Structure of the Plant Toxin Gelonin

Also Published As

Publication number Publication date
AU2547692A (en) 1993-04-05
WO1993005168A1 (en) 1993-03-18
DE69227519T2 (de) 1999-06-02
ATE173023T1 (de) 1998-11-15
RU94034733A (ru) 1996-06-10
FI941048A0 (fi) 1994-03-04
KR100270195B1 (ko) 2001-03-02
CN1047402C (zh) 1999-12-15
NO317659B1 (no) 2004-11-29
RU2142015C1 (ru) 1999-11-27
IL103057A (en) 1999-09-22
EP0602144A1 (en) 1994-06-22
IL103057A0 (en) 1993-02-21
FI941048L (fi) 1994-03-04
DE69227519D1 (de) 1998-12-10
EP0602144A4 (en) 1995-03-15
CA2115049A1 (en) 1993-03-18
JPH06510431A (ja) 1994-11-24
NZ244220A (en) 1994-12-22
NO940736L (no) 1994-03-03
AU679427B2 (en) 1997-07-03
CN1070227A (zh) 1993-03-24
EP0602144B1 (en) 1998-11-04
NO940736D0 (no) 1994-03-03
CA2115049C (en) 2003-10-21
ZA926705B (en) 1993-04-28
FI113547B (fi) 2004-05-14
US5624827A (en) 1997-04-29
DK0602144T3 (da) 1999-07-19

Similar Documents

Publication Publication Date Title
ES2123008T3 (es) Secuencias de adn que codifican polipeptido de gelonina.
ES2181674T3 (es) Dominios de union en las proteinas notch y delta.
ES8302774A1 (es) Un metodo para producir un vector de clonacion mejorado.
ES2127829T3 (es) Expresion de proteinas recombinantes fusionadas en bacterias atenuadas.
AR243234A1 (es) Un gen quimerico modificado que codifica una proteina insecticida de bacillus thuringiensis,un vector que lo contiene, y un metodo para mejorar la expresion de un gen heterologo.
FR2741892B1 (fr) Procede de preparation d'une banque multicombinatoire de vecteurs d'expression de genes d'anticorps, banque et systemes d'expression d'anticorps "coliclonaux" obtenus
ES2111066T3 (es) Unidad minima de reconocimiento de un anticuerpo monoclonal especifico con repeticion del tandem mucina pem.
ES2153037T3 (es) Lacasas purificadas de scytalidium y acidos nucleicos que las codifican.
ES2054878T3 (es) Expresion de la proapolipoproteina a-i humana.
ES2061482T3 (es) Metodo para la identificacion de secuencias de señal secretora para sintesis de proteina extracelular en bacillus.
ES2077666T3 (es) Proteina de union a fibronectina y su preparacion.
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
DK320686A (da) Ekspressionskontrolsekvenser
IT8119760A0 (it) Polipeptide prodotto microbiologicamente con la sequenza di aminoacidi dell'interferone umano, dna e plasmidi che codificano per questa sequenza, microorganismi che contengono queste informazioni genetiche e processo per la loro preparazione.
HUT71847A (en) Dna molecules encoding aminopeptidase enzymes, vectors and transgenic cells containing dna molecules, immunogenic polypeptides encoding by dna molecules, vaccines against helminth infections containing these peptides and process for the preparation ...
DE69839566D1 (de) Chimäre polypeptide, die das fragment b des shigatoxins sowie peptide von therapeutischem interesse enthalten
DE69533359D1 (de) Veränderte menschliche c3-proteine
NO974035L (no) En ny vekstfaktor og en genetisk sekvens som koder for denne
DE3683447D1 (de) Verfahren zur herstellung von humanlysozym.
FI961202A0 (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
ZA916171B (en) Protein structure of the plant toxin gelonin
CO4480058A1 (es) Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa
FR2692282B1 (fr) Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
AR006150A1 (es) Proteina de via complementaria natural modificada capaz de formar una convertasa c3 resistente a la regulacion descendente, secuencias de adn quecodifican dicha proteina, usos de dicha proteina y composiciones que la contienen
ATE302214T1 (de) Enamel-matrix bezogene polypeptide

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 602144

Country of ref document: ES